Congenital diarrhoea due to microvillus inclusion disease: a case report
DOI:
https://doi.org/10.18203/2349-3291.ijcp20243492Keywords:
Congenital, Diarrhea, Microvillous, Genetic, EnteropathiesAbstract
Inherited diarrheal diseases are group of disorders which cause significant morbidity with dependence on parental nutrition. Microvillus inclusion disease (MVID) is a secretory enteropathy with autosomal recessive inheritance associated with bi allelic mutations in MYO5B gene or more rarely STX3 gene. We report a newborn, which developed diarrhea since birth and whose exome sequencing showed the rare mutation of biallelic STX3. There is a possibility of familial involvement (two other siblings having similar symptoms involved, but not evaluated and died) in this particular case. All three had antenatal polyhydramnios and dilated bowel loops. This case report describes an infant diagnosed with congenital diarrhea due to a genetic mutation, explores the diagnostic process, and outlines the management strategies and outcomes. The report emphasizes the importance of early diagnosis and tailored treatment in improving patient outcomes.
References
Thiagarajah JR, Kamin DS, Acra S. Advances in evaluation of chronic diarrhoea in infants. Gastroenterol. 2018;154(08):20-45.
Müller T, Hess MW, Schiefermeier N, Pfaller K, Ebner HL, Heinz-Erian P, et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nature Genetics. 2008;40:1163-5.
Wiegerinck CL, Janecke AR, Schneeberger K, Vogel GF, Van Haaften-Visser DY, Escher JC, et al. Loss of Syntaxin 3 Causes Variant Microvillus Inclusion Disease. Gastroenterol. 2014;147(1):65-8.
Cutz E, Rhoads JM, Drumm B, Sherman PM, Durie PR, Forstner GG. Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med. 1989;320(10):646-51.
Dhekne HS, Pylypenko O, Overeem AW, Zibouche M, Ferreira RJ, van der Velde KJ, et al. MYO5B, STX3, and STXBP2 mutations reveal a common disease mechanism that unifies a subset of congenital diarrheal disorders: a mutation update. Hum Mutat. 2018;39(3):333-44.
Leng C, Rings EHHM, Wildt SN, van IJzendoorn SCD. Pharmacological and parenteral nutrition-based interventions in microvillus inclusion disease. J Clin Med. 2020;10(1):22.
Ruemmele FM, Müller T, Schiefermeier N. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model. Hum Mutat. 2010;31(5):544-51.
Terrin G, Tomaiuolo R, Passariello A. Congenital diarrheal disorders: an updated diagnostic approach. Int J Mol Sci. 2012;13(4):4168-85.
Ruemmele FM, Schmitz J, Goulet O. Microvillous inclusion disease (microvillous atrophy) Orphanet J Rare Dis. 2006;1:22.
Canani RB, Terrin G. Recent progress in congenital diarrheal disorders. Curr Gastroenterol Rep. 2011;13(3):257-64.
Janecke AR, Liu X, Adam R, Punuru S, Viestenz A, Strauß V, et al Pathogenic STX3 variants affecting the retinal and intestinal transcripts cause an early-onset severe retinal dystrophy in microvillus inclusion disease subjects. Hum Genet. 2021;140(8):1143-56.
Datta P, Gilliam J, Thoreson WB, Janz R, Heidelberger R. Two pools of vesicles associated with synaptic ribbons are molecularly prepared for release. Biophys J. 2017;113(10):2281-98.
Sun Y, Leng C, Van Ijzendoorn SCD. Fetal bowel abnormalities suspected by ultrasonography in microvillus inclusion disease: prevalence and clinical significance. J Clin Med. 2022;11(15):4331.
